Asia-Pacific AI-assisted Imaging Market Report 2025-2032 | $7.3B Asia-Pacific AI Imaging Market by 2032 Amid Accelerating Hospital and OEM Adoption

Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific AI-assisted Imaging Market 2025-2032" report has been added to ResearchAndMarkets.com's offering.

APAC is the fastest growing region in AI imaging, moving from ~US$0.61B (2023) to ~US$7.3B (2032) -about 31% CAGR-and overtakes Europe before decade end.

Buyers need region specific evidence, attach rate ladders, and country GTM tools to move from pilots to scale; this Pulse report delivers exactly that, in one region focused volume.

Snapshots & Takeaways

APAC growth arc: ~US$0.61B -> ~US$7.3B (2023-2032), ~31% CAGR; APAC's share of the global market nears 30% by 2032.Where revenue concentrates: CT/MR remain the core; fastest unit scale comes from POCUS ultrasound and low bandwidth DR in India/ASEAN; PET/Nuclear grows off oncology theranostics.Clinical engines: Oncology, Neurology (stroke), and Cardiology together deliver ~75% of absolute growth to 2032.Shift in revenue mix: Hardware share declines as fleets modernize; Software + Cloud/Pay per Use expand fastest (enterprise suites in JP/KR/ANZ; pay per study in India/ASEAN).Attach rate baseline: CT ~10% -> rising with OEM bundles; MR ~8%; DR ~6%; retrofit dominates incremental dollars as the installed base upgrades.What to act on in 12 months: File top modules per market (NMPA/PMDA/MFDS/TGA/HSA/CDSCO), pre validate on local clouds (data residency), lead with AI recon + stroke triage (JP/KR/ANZ) and DR chest/echo AI pay per study (India/ASEAN).

Who Should Buy

Imaging OEMs, PACS/VNA and cloud vendors building APAC bundles and tendersAI pure plays localizing modules and pricing for China, India, ASEAN, Japan/Korea, and ANZProvider networks (hospital groups, teleradiology hubs) planning enterprise "AI store" rolloutsInvestors and channel partners vetting evidence, regulatory velocity and GTM maturity

Buyer Benefits

Size the opportunity by country and segment with defendable numbers tied to attach rate assumptions (CT ~10% of new units; MR ~8%; DR ~6% base year).Prioritize where to play using regional frameworks (GTM Growth & Maturity, Regulatory Velocity, GTM Readiness) and country tiered landscapes/timelines.Localize go to market with regulatory and procurement checklists (NMPA, PMDA, MFDS, TGA, HSA, CDSCO), cloud/data residency cues, and pricing archetypes (license vs. pay per use).De risk pricing & deployment with Numbers in Context (OEM vs. pure play split, retrofit share, attach rate ladder) and Pulse Quick Actions for the next 12 months.Evidence & QA ready-every table and split passes a documented QA loop and cites the evidence stack used in the APAC model.

Methodology & QA

Forecasts reconcile top down APAC totals to the global rollup and bottom up attach rate flows by modality (shipments, installed base upgrades, factory vs. retrofit attach, and local ASP bands). The APAC model is anchored by regulatory lines NMPA / PMDA / MFDS / TGA / HAS / CDSCO), ABDM digital health rails for India, and peer reviewed RWE. A four point QA loop checks reconciliation variance (Less than or equal to 0.5%), regulatory count deltas, evidence freshness, and ASP sanity for each country/modality.

Countries/Regions Covered

ChinaJapanIndiaS. KoreaAustraliaROAPAC

Key Topics Covered:

SECTION 1 - EXECUTIVE SUMMARY

The 25-second ReadSize & Pace (Who Contributes What by 2032)Where Growth ConcentratesCountry/Cluster SnapshotsAPAC Watchlist (What to Act on in the Next 12 months)Pulse Quick Actions (12 Months)

SECTION 2 - RESEARCH METHODOLOGY

ObjectiveDual-lens ArchitectureAPAC-specific Evidence & InputsModel Calibration Choices (APAC)Limitations & Mitigations (APAC)Quality Assurance Loop

SECTION 3 - ASIA-PACIFIC (APAC) MARKET

Size, Trajectory & Strategic ImportanceDemand Drivers & HeadwindsCompetitive & Partnership LandscapeStrategic Clustering & Go-to-Market NuancesStrategic RecommendationsRegulatory / Policy (What's New or Clarified)AI Imaging Market by Country - APACMarkintel GTM Growth and Maturity Matrix - APACCompetitive Data Set - APACNumbers-in-Context - APACStrategic Takeaways - APACGrowth & Maturity Highlights - APACM&A Watchlist - APACRegulatory Velocity - APACOEM AI Attach Rate - APACAttach-Rate Trends - APACFactory vs Retrofit AttachGTM at-a-Glance - APACGTM Readiness Radar - APACTiered Customer Landscape - APACGTM Timeline - APACAdjacency Opportunity Matrix - APACCountry-Cluster Framework - APACWhite Space Partner Framework - APACRegulatory Funding Heatmap - APACChannel x Pricing Matrix - APACFast Strategic Cues - APAC

SECTION 4 - CHINESE MARKET

China - Market Overview & Strategic Summary (2023-2032)Urban-Rural Duality MattersStrategic TakeawaysChinese Market Forecasts (2023-2032)Chinese Market by Clinical Area (2023-2032)Chinese Market by Modality (2023-2032)Chinese Market by Revenue Stream (2023-2032)Chinese Market by Clinical Application (2023-2032)Chinese Market by End-Use Organization (2023-2032)Chinese Market by AI Technology (2023-2032)Markintel Growth Maturity Matrix - China AI in Medical ImagingExecutive CommentaryCross-Quadrant Insights & Tactical GuidancePriority Recommendations (next 18 months)Competitive Dataset - ChinaMarkintel Ecosystem Collaboration Matrix - ChinaThree Rules for Winning the Collaboration GameQuick hit Actions for BD teams (Next Two Quarters)Markintel Solution Adoption and Growth Matrix - ChinaTranslating the Matrix into ActionExecution Priorities by Function"First 100-Days" ChecklistMetrics that MatterOperating Roadmap TakeawayGTM at a Glance - ChinaGTM Readiness Radar - ChinaTiered Customer Landscape - ChinaGTM Timeline - ChinaAdjacency-Opportunity?Radar -?ChinaRegulatory Funding Heatmap - ChinaChannel Pricing Matrix - ChinaWhite Space Partnership Matrix - China

SECTION 5 - JAPANESE MARKET

Market Overview & Strategic Summary: JapanStrategic OutlookAction PointsJapanese Market Forecasts (2023-2032)Japanese Market by Clinical Area (2023-2032)Japanese Market by Modality (2023-2032)Japanese Market by Clinical Application (2023-2032)Japanese Market by End-Use Organization (2023-2032)Japanese Market by AI Technology (2023-2032)Markintel Solution Adoption & Growth Matrix - JapanTurning the Matrix into an Operating Road Map for Japan (2024 28)Markintel Ecosystem Collaboration Matrix - JapanTurning the Matrix into an Operating RoadmapPlaybook Highlights by QuadrantRisk Checkpoints & MitigationsGo-to-Market (GTM) Playbook - JapanGTM Readiness Radar - JapanTiered Customer Landscape - JapanGTM Timeline - JapanAdjacency Opportunity Radar - JapanRegulatory Funding Heatmap - JapanChannel x Pricing Matrix - JapanWhite Space Partnership Matrix - JapanFast Strategic Cues

SECTION 6 - INDIAN MARKET

Market Overview & AnalysisMarket MechanicsConstraint MapCompetitive TemperatureActionable Opportunities (2024-26 Window)Go Forward Recommendations (by player type)What Success Looks LikeIndian Market Forecasts (2023-2032)Indian Market by Clinical Area (2023-2032)Indian Market by Modality (2023-2032)Indian Market by Revenue Stream (2023-2032)Indian Market by Clinical Application (2023-2032)Indian Market by End-Use Organization (2023-2032)Indian Market by AI Technology (2023-2032)Markintel Solution Adoption & Growth Matrix - IndiaSolution Classes and Action CuesStrategic Interpretation & Operating RoadmapOne-Page Operating ChecklistMarkintel Ecosystem Collaboration Matrix - IndiaOperating Roadmap: Leveraging India's Collaboration MatrixStrategic Sequencing (2024 27)Execution TipsKey Metrics to TrackCompetitive Landscape -?IndiaOperating RoadmapGTM at a Glance - IndiaGTM Readiness Radar - IndiaTiered Customer Landscape - IndiaGTM Timeline - IndiaAdjacency-Opportunity Radar - IndiaRegulatory x Funding Heatmap - IndiaWhite-Space Partnership MatrixChannel??Pricing MatrixFast Strategic Cues (Do This First)

SECTION 7 - SOUTH KOREAN MARKET

Market Summary & Overview: South KoreaKey Market DynamicsStrategic TakeawaysTop 3 RecommendationsSouth Korea Market ContextSouth Korean Market Forecasts (2023-2032)South Korean Market by Clinical Area (2023-2032)South Korean Market by Modality (2023-2032)South Korean Market by Revenue Stream (2023-2032)South Korean Market by Clinical Application (2023-2032)South Korean Market by End-Use Organization Type (2023-2032)South Korean Market by AI Technology (2023-2032)GTM at a Glance - South KoreaSix-Pillar GTM Readiness Radar - South KoreaTiered Customer Landscape - South KoreaFive-Step GTM Timeline - South KoreaAdjacency-Opportunity Radar - South KoreaRegulatory x Funding Heatmap - South KoreaWhitespace Partnership Matrix - South KoreaChannel??Pricing Matrix - Typical 2025 DealsFast Strategic Cues

SECTION 8 - AUSTRALIAN MARKET

Market Overview & AnalysisMarket Structure & Growth DriversSegment Hotspots (Qualitative Sizing)Competitive LandscapeStrategic Implications & GTM PrioritiesAction-Oriented Recommendations (Next 12 Months)Australian Market Forecasts (2023-2032)Australian Market by Clinical Area (2023-2032)Australian Market by Modality (2023-2032)Australian Market by Revenue Stream (2023-2032)Australian Market by Clinical Application (2023-2032)Australian Market by End-Use Organization (2023-2032)Australian Market by AI Technology (2023-2032)GTM at a Glance - AustraliaGTM Readiness Radar - AustraliaGTM Timeline - AustraliaAdjacency-Opportunity Radar - AustraliaRegulatory x Funding Heatmap

SECTION 9 - REST OF ASIA-PACIFIC (ROAPAC) MARKET

Market Overview & AnalysisRegional ClustersMarket Dynamics - What's Shaping Buying DecisionsActionable RecommendationsQuick-Hit Opportunities by ClusterWhat Success Looks LikeRest of Asia-Pacific Market Forecasts (2023-2032)Rest of Asia-Pacific (ROAPAC) Market by Clinical Area (2023-2032)Rest of Asia-Pacific (ROAPAC) Market by Modality (2023-2032)Strategic InsightsRest of Asia-Pacific (ROAPAC) Market by Revenue Stream (2023-2032)Rest of Asia-Pacific (ROAPAC) Market by Clinical Application (2023-2032)Rest of Asia-Pacific (ROAPAC) Market by End-Use Organization (2023-2032)Rest of Asia-Pacific (ROAPAC) Market by AI Technology (2023-2032)GTM at a Glance - ROAPACGTM Readiness Heatmap - ROAPAC ClustersFive-Step GTM Roll Out Timeline (2024 2029) - Keyed to Clusters

For more information about this report visit https://www.researchandmarkets.com/r/q5hk9p

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.